Go to deals
Healthcare

IceCure Medical has issued bonds worth US$5.7 million

IceCure Medical Ltd. has completed a fundraising to refinance and develop the company.

IceCure is an Israeli medical device company that has developed technology to eliminate benign and cancerous tumors in the breast and other parts of the body by freezing the tumor during treatment in a clinic and without surgery, using the ProSense system developed at the Elisha Private Hospital in Haifa.

Oaklins’ team in Israel advised IceCure Medical Ltd. and acted as the leader of the distributors’ consortium.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Ruben  Eblagon

Ruben Eblagon

Principal

Tel Aviv, Israel
Oaklins Rosario
 Boaz  Levi

Boaz Levi

Partner

Tel Aviv, Israel
Oaklins Rosario

Related deals

ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners
Healthcare | TMT

ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners

Netherlands-based ScreenPoint Medical, an AI technology company that develops advanced image recognition and machine learning software to improve early detection of breast cancer, has raised US$28 million (€24 million) in a Series C funding round led by New York-based global venture capital and private equity firm Insight Partners to further develop its technology and accelerate commercial growth of the company’s Transpara AI breast care software.

Learn more
Poolbeg Pharma has completed an Initial Public Offering on AIM
Healthcare

Poolbeg Pharma has completed an Initial Public Offering on AIM

Poolbeg Pharma Plc has raised funds to develop the company.

Learn more
Kungshusen Medicinska has been acquired by Diploma
Healthcare

Kungshusen Medicinska has been acquired by Diploma

Kungshusen Medicinska AB has been acquired by Diploma PLC. Through the acquisition, Diploma gains access to a unique platform for the distribution of medtech products in Sweden.

Learn more